Trial Profile
Efficacy and safety of Low-dose Acitretin (10mg) compared with the High-dose (25mg) in patients with Palmoplantar psoriasis
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 08 May 2018
Price :
$35
*
At a glance
- Drugs Acitretin (Primary)
- Indications Palmoplantar pustulosis
- Focus Adverse reactions; Therapeutic Use
- 08 May 2018 New trial record